Drug · DIN 02148749
DIFFERIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 31, 1996; first marketed December 31, 1996.
- Drug Identification Number (DIN)
- 02148749
- Company (DIN owner)
- Galderma Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Adapalene D10AD03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADAPALENE | 0.1 % |
Other DINs named DIFFERIN
- DIN 02231592 · Marketed
- DIN 02148757 · Cancelled Post Market
- DIN 02376660 · Approved